PERSPECTA

News from every angle

← Back to headlines

Halozyme Projects Over $1B in ENHANZE Royalties by 2026, Announces $1B Share Buyback

Halozyme Therapeutics has outlined projections for its ENHANZE royalties to exceed $1 billion by 2026 and announced a new $1 billion share buyback program.

12 May, 02:53 — 12 May, 02:53
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed87d ago

Halozyme outlines ENHANZE royalties exceeding $1B in 2026 while launching a new $1B buyback

Read full article →

Related Stories

Problems with Access to Drug Programs and Modern Therapies in Poland

25m ago

Cyclist Dies in Hospital Following Severe Accident in Slovenia

42m ago

Study Links C-Sections to Reduced Chances of Future Pregnancy

42m ago

Dermatologist Warns Against Accutane 'Beauty-Hype'

49m ago